Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells (CFTC) for Triplet Repeat Diseases

NCT03087526 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03087526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Invasive Prenatal Diagnosis on Isolated Circulating Fetal Trophoblastic Cells (CFTC) for Triplet Repeat Diseases
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2017
Completion date
April 1, 2020
Enrollment
60 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

non invasive prenatal diagnosis